Galapagos (Euronext: GLPG; OTC: GLPYY) is a mid-size biotechnology company specialized in the discovery and development of small molecule and antibody therapies with novel modes-of-action. The Company is progressing one of the largest pipelines in biotech, with six clinical and over 50 small molecule discovery/pre-clinical programs. Through risk/reward-sharing alliances with GlaxoSmithKline, Lilly, Janssen Pharmaceutica, Merck & Co., Roche and Servier, Galapagos is eligible to receive up to €3.3 billion in downstream milestones, plus royalties. The Galapagos Group has over 800 employees and operates facilities in seven countries, with global headquarters in Mechelen, Belgium.
Company Growth (employees)
Mechelen, BE
Size (employees)
550 (est)+15%
Galapagos was founded in 1999 and is headquartered in Mechelen, BE

Key People at Galapagos

Onno van de Stolpe

Onno van de Stolpe

Werner Cautreels

Werner Cautreels


Galapagos Office Locations

Galapagos has an office in Mechelen

Galapagos Data and Metrics

Galapagos Financial Metrics


Market capitalization (22-Sep-2017)

4.2 b

Closing share price (22-Sep-2017)

Galapagos's current market capitalization is €4.2 b.
Show all financial metrics

Galapagos Market Value History

Traffic Overview of Galapagos

Galapagos Online and Social Media Presence

Galapagos News and Updates

Who Created Emojis? A 25-Year-Old Developer on a Deadline

"I'm neither an artist nor a designer," says Shigetaka Kurita.

Resurrecting a Long-Lost Galapagos Giant Tortoise

It may be possible to resurrect the Floreana tortoise, by studying a long-lost population left by pirates on an extinct volcano.

“Ghost poachers” are still at large after the biggest shark-smuggling bust in Galapagos history

On Aug. 13, Ecuadorian authorities intercepted a Chinese ship crossing the Galapagos Marine Reserve, one of the most heavily protected nature reserves in the world.…

Galapagos Company Life and Culture

You may also be interested in